Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
北京拓领博泰生物科技
Beijing, Beijing, Chinatobu.co.jp ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Beijing Tuoling Botai Biotech specializes in innovative drug and therapy development for autoimmune diseases using advanced immunomodulatory technologies. The company collaborates with leading academic institutions such as Tsinghua University and Peking Union Medical College Hospital. Clinical results or late-stage programs are not publicly disclosed.[5]
- Therapeutic areas
- Immunology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
Tsinghua UniversityPeking Union Medical College Hospital
Beyond the preview
Go deeper on 北京拓领博泰生物科技.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 北京拓领博泰生物科技.